| |
|
|
|
|
|
|
|||
|
RK Strair, M Towle, PW Heald and BR Smith
Department of Internal Medicine, Yale University School of Medicine, New
Haven, CT 06510.
In this report we describe the use of recombinant retroviruses to
characterize the activity of an exogenous promoter in primary cells
obtained from patients with lymphoproliferative disorders. The infection of
a variety of cultured and primary lymphoid cells with a recombinant
retrovirus containing a histone promoter-driven beta- galactosidase gene is
shown to result in the expression of beta- galactosidase in 50% to 100% of
the cells. A similar infection with a recombinant retrovirus containing the
beta-galactosidase gene with an adenovirus E2 promoter, results in
beta-galactosidase activity in a limited number of cultured and primary
cells. Since the adenovirus E2 promoter has been well characterized and is
known to be regulated by transactivators encoded by many viruses, the
activity of this promoter in specific cell types is discussed in reference
to both the biology of the cell and the possible presence of as yet
undetected viral gene products.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1990 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||